Association between Disgust Sensitivity during Pregnancy and Endogenous Steroids: A Longitudinal Study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023761%3A_____%2F24%3AN0000043" target="_blank" >RIV/00023761:_____/24:N0000043 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.3390/ijms25136857" target="_blank" >https://doi.org/10.3390/ijms25136857</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/ijms25136857" target="_blank" >10.3390/ijms25136857</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Association between Disgust Sensitivity during Pregnancy and Endogenous Steroids: A Longitudinal Study
Popis výsledku v původním jazyce
The emotion of disgust protects individuals against pathogens, and it has been found to be elevated during pregnancy. Physiological mechanisms discussed in relation to these changes include immune markers and progesterone levels. This study aimed to assess the association between steroids and disgust sensitivity in pregnancy. Using a prospective longitudinal design, we analyzed blood serum steroid concentrations and measured disgust sensitivity via text-based questionnaires in a sample of 179 pregnant women during their first and third trimesters. We found positive correlations between disgust sensitivity and the levels of C19 steroids (including testosterone) and its precursors in the Delta 5 pathway (androstenediol, DHEA, and their sulfates) and the Delta 4 pathway (androstenedione). Additionally, positive correlations were observed with 5 alpha/beta-reduced C19 steroid metabolites in both trimesters. In the first trimester, disgust sensitivity was positively associated with 17-hydroxypregnanolone and with some estrogens. In the third trimester, positive associations were observed with cortisol and immunoprotective Delta 5 C19 7 alpha/beta-hydroxy-steroids. Our findings show that disgust sensitivity is positively correlated with immunomodulatory steroids, and in the third trimester, with steroids which may be related to potential maternal-anxiety-related symptoms. This study highlights the complex relationship between hormonal changes and disgust sensitivity during pregnancy.
Název v anglickém jazyce
Association between Disgust Sensitivity during Pregnancy and Endogenous Steroids: A Longitudinal Study
Popis výsledku anglicky
The emotion of disgust protects individuals against pathogens, and it has been found to be elevated during pregnancy. Physiological mechanisms discussed in relation to these changes include immune markers and progesterone levels. This study aimed to assess the association between steroids and disgust sensitivity in pregnancy. Using a prospective longitudinal design, we analyzed blood serum steroid concentrations and measured disgust sensitivity via text-based questionnaires in a sample of 179 pregnant women during their first and third trimesters. We found positive correlations between disgust sensitivity and the levels of C19 steroids (including testosterone) and its precursors in the Delta 5 pathway (androstenediol, DHEA, and their sulfates) and the Delta 4 pathway (androstenedione). Additionally, positive correlations were observed with 5 alpha/beta-reduced C19 steroid metabolites in both trimesters. In the first trimester, disgust sensitivity was positively associated with 17-hydroxypregnanolone and with some estrogens. In the third trimester, positive associations were observed with cortisol and immunoprotective Delta 5 C19 7 alpha/beta-hydroxy-steroids. Our findings show that disgust sensitivity is positively correlated with immunomodulatory steroids, and in the third trimester, with steroids which may be related to potential maternal-anxiety-related symptoms. This study highlights the complex relationship between hormonal changes and disgust sensitivity during pregnancy.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10608 - Biochemistry and molecular biology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of Molecular Sciences
ISSN
1661-6596
e-ISSN
1422-0067
Svazek periodika
25
Číslo periodika v rámci svazku
13
Stát vydavatele periodika
CH - Švýcarská konfederace
Počet stran výsledku
26
Strana od-do
6857
Kód UT WoS článku
001270002500001
EID výsledku v databázi Scopus
2-s2.0-85197391974